The “Guidelines on Similar Biologics” prepared by Central Drugs Standard Control Organization (CDSCO) and the Department of Biotechnology (DBT) lay down the regulatory pathway for a similar biologic claiming to be similar to an already authorized reference biologic.
The “Guidelines on Similar Biologics” prepared by Central Drugs Standard Control Organization (CDSCO) and the Department of Biotechnology (DBT) lay down the regulatory pathway for a similar biologic claiming to be similar to an already authorized reference biologic.
The guidelines address the regulatory pathway regarding manufacturing process and quality aspects for similar biologics.
These guidelines also address the pre-market regulatory requirements including comparability exercise for quality, preclinical and clinical studies and post market regulatory requirements for similar biologics.
For further details visit
https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTU0NA==
One must obtain a drug license to launch a business selling drugs or cosmetics. No one can sell drugs or cosmetics without a drug license. The 1940 Drugs and Cosmetics Act specifies the procedure and ..
A wholesale drug license is required for manufacturing, distribution, sale, or storage of drugs. The Drugs and Cosmetics Act, 1940 outlines the requirements to obtain a manufacturing license in India...
The Central Pollution Control Board (CPCB) issued a directive alert for submission of timely annual reports by all Pollution Implementing and Beneficiary Organisations (PIBOs) to avoid any penalties. ..
Please feel free to talk to us if you have any questions. We endeavour to answer within 24 hours.